Reply to Problematic methodology in a systematic review and meta-analysis of DecisionDx-Melanoma - 10/10/20
Doi : 10.1016/j.jaad.2020.06.009
Bradley N. Greenhaw, MD a, Kyle R. Covington, PhD b, Sarah J. Kurley, PhD b, Yildiray Yeniay, MD e, Nhat Anh Cao, BS f, Kristen M. Plasseraud, PhD b, Robert W. Cook, PhD b, Eddy C. Hsueh, MD c, Brian R. Gastman, MD d, Maria L. Wei, MD, PhD e, f, ⁎
a Dermatology Center of North Mississippi, Tupelo, Mississippi
b Castle Biosciences, Inc, Friendswood, Texas
c St. Louis University, St. Louis, Missouri
d Cleveland Clinic Lerner Research Institute, Cleveland, Ohio
e University of California, San Francisco, California
f Veterans Affairs Medical Center, San Francisco, California
∗Correspondence to: Maria L. Wei, MD, PhD, 1701 Divisadero St, 3rd Floor, San Francisco, CA 94115.1701 Divisadero St, 3rd FloorSan FranciscoCA94115
Le texte complet de cet article est disponible en PDF.
| Funding sources: Supported in part by Castle Biosciences, Inc, Friendswood, Texas |
|
| Conflicts of interest: Drs Covington, Kurley, Plasseraud, and Cook are employees and stockholders at Castle Biosciences, Inc. Drs Greenhaw, and Gastman are on the speakers bureau for Castle Biosciences, Inc. Drs Yeniay, Hsueh, and Wei and Author Cao have no conflicts of interest to declare. |
|
| Reprints not available from the authors. |
© 2020
Publié par Elsevier Masson SAS.
Vol 83 - N° 5
P. e359-e360 - novembre 2020 Retour au numéro
Article précédent
- Problematic methodology in a systematic review and meta-analysis of DecisionDx-Melanoma
- Michael A. Marchetti, Stephen W. Dusza, Edmund K. Bartlett
- The new normal: An approach to optimizing and combining in-person and telemedicine visits to maximize patient care
- Jeffrey M. Cohen, Christopher G. Bunick, Sara H. Perkins
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?